Evidence map›Paper›PMID 39639105›Full record

ArticleCommunications biology2024

Dynamic pre-structuration of lipid nanodomain-segregating remorin proteins.

Zeren Xu, Adrien Schahl, Marie-Dominique Jolivet, Anthony Legrand, Axelle Grélard, Mélanie Berbon, Estelle Morvan, Louis Lagardere, Jean-Philip Piquemal, Antoine Loquet and 4 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zeren XuUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID 0009-0005-5034-1297
Adrien SchahlInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400, Toulouse, France.ORCID 0000-0001-5839-7715
Marie-Dominique JolivetLaboratoire de Biogenèse Membranaire (LBM) UMR-5200, CNRS-Univ. Bordeaux, F-33140, Villenave d'Ornon, France.
Anthony LegrandUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.
Axelle GrélardUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID 0000-0002-6708-2253
Mélanie BerbonUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.
Estelle MorvanUniv. Bordeaux, CNRS, Inserm, IECB, UAR3033, US01, Pessac, France.
Louis LagardereSorbonne Université, LCT, UMR7616 CNRS,75005Paris, France; Qubit Pharmaceuticals, Advanced Research Department, 75014, Paris, France.
Jean-Philip PiquemalSorbonne Université, LCT, UMR7616 CNRS,75005Paris, France; Qubit Pharmaceuticals, Advanced Research Department, 75014, Paris, France.ORCID 0000-0001-6615-9426
Antoine LoquetUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France.ORCID 0000-0001-7176-7813
Véronique GermainLaboratoire de Biogenèse Membranaire (LBM) UMR-5200, CNRS-Univ. Bordeaux, F-33140, Villenave d'Ornon, France.
Matthieu ChaventInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, Université Paul Sabatier, 31400, Toulouse, France. Matthieu.Chavent@ipbs.fr.ORCID 0000-0003-4524-4773
Sébastien MongrandLaboratoire de Biogenèse Membranaire (LBM) UMR-5200, CNRS-Univ. Bordeaux, F-33140, Villenave d'Ornon, France. sebastien.mongrand@u-bordeaux.fr.ORCID 0000-0002-9198-015X
Birgit HabensteinUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, IECB, F-33600, Pessac, France. b.habenstein@cbmn.u-bordeaux.fr.ORCID 0000-0003-3723-9552

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-19-CE13-0021Agence Nationale de la Recherche (French National Research Agency) ANR-23-CE11-0005-01Centre National de la Recherche Scientifique (National Center for Scientific Research) CNRS Momentum
6 · The paper itself

Abstract

Remorins are multifunctional proteins, regulating immunity, development and symbiosis in plants. When associating to the membrane, remorins sequester specific lipids into functional membrane nanodomains. The multigenic protein family contains six groups, classified upon their protein-domain composition. Membrane targeting of remorins occurs independently from the secretory pathway. Instead, they are directed into different nanodomains depending on their phylogenetic group. All family members contain a C-terminal membrane anchor and a homo-oligomerization domain, flanked by an intrinsically disordered region of variable length at the N-terminal end. We here combined molecular imaging, NMR spectroscopy, protein structure calculations and advanced molecular dynamics simulation to unveil a stable pre-structuration of coiled-coil dimers as nanodomain-targeting units, containing a tunable fuzzy coat and a bar code-like positive surface charge before membrane association. Our data suggest that remorins fold in the cytosol with the N-terminal disordered region as a structural ensemble around a dimeric anti-parallel coiled-coil core containing a symmetric interface motif reminiscent of a hydrophobic Leucine zipper. The domain geometry, the charge distribution in the coiled-coil remorins and the differences in structures and dynamics between C-terminal lipid anchors of the remorin groups provide a selective platform for phospholipid binding when encountering the membrane surface.

Indexed as

Molecular Dynamics SimulationArabidopsis ProteinsCarrier ProteinsPlant ProteinsProtein DomainsArabidopsis ProteinsCarrier ProteinsPlant Proteinsremorin

Identifiers

PMID39639105
PMCPMC11621693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.